Merrimack (MACK) Buy Rating Reiterated at Cantor Fitzgerald
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/9/2026
- S&P 500, Nasdaq end lower as crude prices jump, chip stocks weigh
- Oil rises 4% on revived Middle East worries, Hurricane Isaias supply disruption
- Chipotle, Starbucks shares volatile after report of potential takeover
- Why Citi says the Fed could be setting up for a dovish surprise
- Alphabet shares rise as Google pushes Gemini deeper into enterprise AI
| Baxter International Inc. (NYSE: BAX) | Delayed: 23.90 -0.07 (0.29%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $23.97 | 52 Week High | $50.16 | |||
| Open | $23.97 | 52 Week Low | $34.06 | |||
| Day High | $24.14 | P/E | 6.53 | |||
| Day Low | $23.50 | EPS | $3.66 | |||
| Volume | 7,561,638 | |||||
| MERRIMACK PHARM (NASDAQ: MACK) | Delayed: 15.13 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $15.13 | 52 Week High | $9.63 | |||
| Open | $0.00 | 52 Week Low | $4.39 | |||
| Day High | $15.13 | P/E | N/A | |||
| Day Low | $15.13 | EPS | $-1.24 | |||
| Volume | 3,325,453 | |||||
